A randomized, double-blind, placebo-controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use

Plasma Cannabinoid Pharmacokinetics following Controlled Oral  9-Tetrahydrocannabinol and Oromucosal Cannabis Extract Administration

(2010) E. L. Karschner et al.   CLINICAL CHEMISTRY

Subjective and Objective Effects of the Novel Triple Reuptake Inhibitor Tesofensine in Recreational Stimulant Users

(2010) K A Schoedel et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Effect of eslicarbazepine acetate and oxcarbazepine on cognition and psychomotor function in healthy volunteers

(2010) Denise Milovan et al.   EPILEPSY & BEHAVIOR

The endocannabinoid system: Its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation

(2009) Vincenzo Di Marzo   PHARMACOLOGICAL RESEARCH

The role of human drug self-administration procedures in the development of medications

(2008) S.D. Comer et al.   DRUG AND ALCOHOL DEPENDENCE

Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Δ9-tetrahydrocannabinol

(2008) Robert E. Vann et al.   DRUG AND ALCOHOL DEPENDENCE

Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users

(2008) JG Ramaekers et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Blunted Psychotomimetic and Amnestic Effects of Δ-9-Tetrahydrocannabinol in Frequent Users of Cannabis

(2008) Deepak Cyril D'Souza et al.   NEUROPSYCHOPHARMACOLOGY

The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin

(2007) R G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY